Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg
LIGAND PHARMACEUTICALS INC
Bioequivalence
1 trial -
Randomised, relative bioavailability clinical trial of amylmetacresol, dichlorobenzyl alcohol, lidocaine and vitamin c lozenges after a single oral dose administration to healthy volunteers under fasting conditions in a crossover design.
Lacuna Pharma Pty Ltd
healthy volunteer
1 trial -
Randomized, double-blind, placebo-controlled, two-part study assessing the safety, tolerability and pharmacokinetics of BP1.7881 administered as higher doses, after single ascending doses (Part I) and multiple ascending doses (Part II), including the assessment of BP1.7881 on cardiac repolarization, in healthy subjects.
Bioprojet Pharma
Eosinophilic esophagitis
1 trial -
Randomized, open-label, laboratory-blinded, balanced, single dose, 3-treatment, 6-sequence, 3-period crossover comparative bioavailability study comparing Finerenone, 20 mg, film-coated tablets (Prototype 1, Prototype 2) and Kerendia, 20 mg, film-coated tablets under fasting conditions in healthy participants.
Lacuna Pharma Pty Ltd
Comparative bioavailability study under fasting conditions
1 trial -
Randomized, open-label, replicated single-dose, 4-period, 2-sequence crossover study to assess the comparative bioavailability of test product Amlodipine/Valsartan/Hydrochlorothiazide 10 mg/160 mg/12.5 mg film-coated tablets to reference product Exforge HCT 10 mg/160 mg/12.5 mg film-coated tablets in healthy male and female subjects under fasting conditions.
Lacuna Pharma Pty Ltd
not applicable (submitted trial is bioavailability)
1 trial -
Randomized, open-label, single dose, two-period, two-treatment, cross-over bioequivalence study comparing test product Rivaroxaban/Acetylsalicylic acid, tablet, 2.5 mg/50 mg (given as two tablets) to reference product Xarelto 2.5 mg film-coated tablets (given as two tablets) and Aspirin® N 100 mg tablet in healthy male and female subjects under fasting conditions.
Lacuna Pharma Pty Ltd
not applicable (submitted trial is a bioequivalence in healthy subjects)
1 trial -
Recombinant SARS-CoV-2 Fusion Protein Vaccine
Livzon Pharmaceutical Group
COVID19
1 trial -
Recombinant erythropoietin stimulating protein
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Chronic Renal Failure
1 trial -
Recombinant human thrombopoietin
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Liver Cirrhosis
1 trial -
Repomol, Metronidazol ”Baxter” Viaflo, infusionsvæske, opløsning, Saline Solution Basi 9 mg/ml solution for infusion, Fosfomycin "Infectopharm", pulver til infusionsvæske, opløsning 40 mg/ml
Lacuna Pharma Pty Ltd
peritonitis
1 trial -
Reslizumab IV
Teva Pharma GmbH
Absolute Bioavailability
1 trial -
Revumenib
Syndax Pharmaceuticals
Relapsed/Refractory Leukemias
1 trial -
Revumenib
Syndax Pharmaceuticals
Refractory Acute Myeloid Leukemia
1 trial -
Revumenib
Syndax Pharmaceuticals
Blinatumomab
1 trial -
Revumenib
Syndax Pharmaceuticals
Acute Leukemia
1 trial -
Ribavirin 200 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Risperidone
Teva Pharma GmbH
Healthy
2 trials -
Rongliflozin
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Type 2 Diabetes Mellitus
1 trial -
Ropinirole HCl 0.25 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Rose bengal disodium
PROVECTUS BIOPHARMACEUTICALS, INC.
Neuroendocrine Tumors Metastatic to the Liver
1 trial -
Rowasa® 4 gm/60 mL Rectal Enema
Teva Pharma GmbH
Healthy
1 trial -
SAGE-718
SUPERNUS PHARMACEUTICALS, INC.
Healthy Volunteer
3 trials -
SAGE-904
SUPERNUS PHARMACEUTICALS, INC.
Healthy Volunteer
1 trial -
SD-809
Teva Pharma GmbH
TOURETTE SYNDROME
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources